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Abstract
Background: Owing to migration, female genital mutilation or cutting (FGM/C) has become a growing concern in
host countries in which FGM/C is not familiar. There is a need for reliable estimates of FGM/C prevalence to inform
medical and public health policy. We aimed to advance methodology for estimating the prevalence of FGM/C in
diaspora by determining the prevalence of FGM/C among women giving birth in the Netherlands.
Methods: Two methods were applied to estimate the prevalence of FGM/C in women giving birth: (I) direct
estimation of FGM/C was performed through a nationwide survey of all midwifery practices in the Netherlands and
(II) the extrapolation model was adopted for indirect estimation of FGM/C, by applying population-based-survey
data on FGM/C in country of origin to migrant women who gave birth in 2018 in the Netherlands.
Results: A nationwide survey among primary care midwifery practices that provided care for 57.5% of all deliveries
in 2018 in the Netherlands, reported 523 cases of FGM/C, constituting FGM/C prevalence of 0.54%. The indirect
estimation of FGM/C in an extrapolation-model resulted in an estimated prevalence of 1.55%. Possible reasons for
the difference in FGM/C prevalence between direct- and indirect estimation include that the midwives were not
being able to recognize, record or classify FGM/C, referral to an obstetrician before assessing FGM/C status of
women and selective responding to the survey. Also, migrants might differ from people in their country of origin in
terms of acculturation toward discontinuation of the practice. This may have contributed to the higher indirect-
estimation of FGM/C compared to direct estimation of FGM/C.
Conclusions: The current study has provided insight into direct estimation of FGM/C through a survey of
midwifery practices in the Netherlands. Evidence based on midwifery practices data can be regarded as a minimum
benchmark for actual prevalence among the subpopulation of women who gave birth in a given year.
Keywords: Female genital mutilation/cutting, Female circumcision, Prevalence, Direct estimation, Indirect
estimation, Midwifery practices, Delivery
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: r.kawous@pharos.nl
1Department of Public Health, Erasmus University Medical Centre, Rotterdam,
the Netherlands
3Pharos, Dutch Centre of Expertise on Health Disparities, Utrecht, the
Netherlands
Full list of author information is available at the end of the article
Kawous et al. BMC Public Health         (2020) 20:1033 
https://doi.org/10.1186/s12889-020-09151-0
Background
Female Genital Mutilation or Cutting (FGM/C) refers to
‘all procedures involving the partial or total removal of
the external female genitalia, or other injury to the fe-
male genital organs for non-medical reasons’ [1]. Four
types of FGM/C are classified, ranging from clitoridec-
tomy (the excision of the prepuce, with or without exci-
sion of part or all of the clitoris) to infibulation (the
excision of part- or all of the external genitalia and
stitching or narrowing of the vaginal opening) [1]. FGM/
C has harmful health consequences [2–7], especially for
women during pregnancy and childbirth [8, 9]. Evidence
shows a significant higher prevalence of ‘prolonged
labor, obstetric lacerations, instrumental delivery, obstet-
ric haemorrhage and difficulty delivery’ among women
with FGM/C compared to women without FGM/C [9].
Other obstetric consequences of FGM/C include fear of
childbirth, difficulty in intrapartum monitoring, difficulty
in catheterization during labor, wound infection and re-
tention of lochia [8]. In addition to obstetric complica-
tions, infants born from women with FGM/C are at
increased risk of stillbirth and early neonatal death [8].
FGM/C is predominantly practiced in countries in Africa,
the Middle East and Asia, where it is estimated that over
200 million girls and women have undergone FGM/C [10].
With an increase in migration, FGM/C is now encountered
in high-resource countries such as the Netherlands. It is es-
timated that about 41,000 girls and women are living in the
Netherlands with effects of FGM/C, of whom 71% were of
reproductive age [11]. The migration from countries where
FGM/C is concentrated to non-practicing countries will
even further increase [12, 13]. Consequently, in the near fu-
ture, more and more health care providers are expected to
provide care for women with FGM/C. Therefore, it is ne-
cessary to have insight into the prevalence of FGM/C, espe-
cially in the obstetric care setting.
Currently, the extrapolation-model has been widely
used in high-resource countries to estimate the number
of women with FGM/C [14]. The extrapolation-method,
also known as ‘indirect estimation’, extrapolates informa-
tion on FGM/C prevalence in countries of origin and ap-
plies country-prevalence (eventually with corrections) to
female migrants in countries of destination. Although
the extrapolation-model has certain advantages such as
not being complex and having low costs, the model may
not provide an accurate picture of the practice in dias-
pora [15], especially regarding mechanisms of migration
flows selection that could lead to underestimation- or
overestimation of the prevalence based on the country
of origin data and changes in FGM/C practice after tak-
ing residence in country of destination that primarily
affect young girls. Therefore, it is crucial to validate the
robustness of indirect estimates of FGM/C through dir-
ect estimation of FGM/C.
In the Netherlands, primary-care midwives are respon-
sible for care provision to women with low-risk of preg-
nancy complications. Women are referred to an
obstetrician in case of complications during pregnancy
or childbirth [16, 17]. Since 89% of pregnant women in
the Netherlands visit a primary care midwifery practice
at least once during their pregnancy [18], we choose to
directly estimate the prevalence of FGM/C through a
survey of midwifery practices. Pregnancy presents the
midwives with a natural opportunity to examine female
genitalia.
The aims of this study were (I) to estimate the preva-
lence of FGM/C through a nationwide survey among
midwifery practices in the Netherlands, and (II) to com-
pare this estimation with indirect estimation of FGM/C
based on an extrapolation-model.
Methods
Direct estimation
Study population and design
A nationwide survey was conducted to determine the
prevalence of FGM/C in primary-care midwifery prac-
tices in the Netherlands. In March 2019, a letter was
sent to all these midwifery practices explaining the pur-
pose of the study, including a questionnaire and a pre-
paid return envelope. The questionnaire was previewed
and screened by the Royal Dutch Organization of Mid-
wives (KNOV) and then improved before sent out. A re-
minder e-mail was sent 3 weeks later to practices that
had not yet completed the paper questionnaire. They
were given the option to complete a Web-based version
of this questionnaire. Two weeks later, they were
reminded by phone in case the questionnaire was not
returned. In total, 503 midwifery practices were invited
to participate in the survey; of these, 336 (66.8%)
returned the questionnaires. Practices who did not re-
turn the questionnaire were mainly located in the largest
cities (i.e., Amsterdam, Rotterdam, Den Haag). Respon-
dents were eliminated if they did not fully answer the
questionnaires, resulting in a working sample of 319
midwifery practices.
Measures
The questionnaire asked about (I) the number of women
who received care in 2018 during pregnancy, birth giving
and postpartum, (II) the number of women with FGM/C
who received midwifery care in 2018, and (III) the num-
ber of women with infibulation (Type III). We did not
include a question about the country of origin, because
the country of origin is not routinely documented in
medical records. Further, in order to reduce the possibil-
ity of recall error, respondents were asked to retrieve
FGM/C cases from medical records. Since health care
providers may experience difficulties in identifying and
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recording FGM/C [19–21], respondents were also asked
to indicate if they were certain about the number of cir-
cumcised women reported. Finally, a free-text field was
included at the end of the survey to allow participants to
comment on their answers if necessary.
Data analysis
Prevalence of FGM/C and its confidence intervals (CIs)
were calculated as described by Snedecor and Cochran
[22]. Using the free-text field, some participants indi-
cated not being able to record or retrieve FGM/C cases
from medical records. Therefore, using the same proced-
ure as described above, we analyzed whether the level of
uncertainty about their assessment and data retrieval
from medical records influenced the reported FGM/C
prevalence per midwifery practice.
Indirect estimation
Methodological approach and study population
We regarded the indirect estimation of FGM/C as a the-
oretical estimation of the expected FGM/C prevalence
among women giving birth. For indirect estimation of
FGM/C, we adopted the extrapolation-model and its
underlying procedure, as described in detail in previous
work [11]. In this study, we combined age-specific
FGM/C prevalence in the country of origin with the age
composition of first-generation migrant women who
gave birth in the Netherlands. When necessary, the
prevalence estimates were adjusted for variations in
FGM/C prevalence across regions within the country of
origin.
In this study, first-generation migrants are considered
girls and women who migrated from one of the 29 coun-
tries with available nationally representative information
on FGM/C, whereas second-generation migrants are con-
sidered girls born in the Netherlands to at least one parent
who has migrated from one of these countries [11, 23].
Data sources and data analysis
Statistics Netherlands (CBS) provided microdata on first-
and second-generation women who gave birth in 2018
in the Netherlands (n = 4598) by age, country of origin,
birth place and date of arrival in the Netherlands. We
excluded data from 546 first-generation women who
missed information primarily regarding age and/or birth
place. Unfortunately, data on ‘migration background’ of
second-generation women (n = 236) were also missing,
consequently they were excluded from the analysis. The
final analysis was performed on 3816 first-generation
women who gave birth in 2018 in the Netherlands.
There is a wide variation in the prevalence of FGM/C
with both within and across countries where the practice
is concentrated [24]. Therefore, adjustments were made
to prevalence data to account for variation in FGM/C
prevalence across regions in the country of origin.
Therefore, we processed the dataset by regrouping mi-
grant girls and women according to region within their
countries of origin, using Microsoft Office Excel (2016)
and IBM SPSS Statistics (version 25.0. Finally, data on
the prevalence of FGM/C for countries of origin were
extracted from the Demographic and Health Survey
(DHS; www.dhsprogram.com) and the Multiple Indica-
tor Cluster Survey (MICS; www.mics.unicef.org/surveys)
country reports, which are publicly-accessible. DHS and
MICS are nationally representative household surveys in
low- and middle-income countries that collect informa-
tion on a variety of indicators related to health, including
FGM/C [24].
Results
Direct estimation
The total study population comprised 96,932 pregnant
women, including women from non-FGM/C practicing
countries, who had received care in 2018 from 319 mid-
wifery practices in the Netherlands, comprising 57.5% of
all deliveries in the Netherlands in 2018. A total of 168
out of 319 (53%) midwifery practices reported providing
care to women with FGM/C. In these practices a total of
523 FGM/C cases were reported, resulting in a preva-
lence of 0.54% (95% Confidence Interval 0.536–0.543) in
about 97,000 women receiving care during pregnancy,
delivery and postpartum (see Table 1). About 32% of the
523 FGM/C cases were reported as infibulation (Type
III).
Using the free-text field, some participants indicated
not being able to record or retrieve FGM/C cases from
medical records. As shown in Table 1, FGM/C preva-
lence among midwifery practices who were sure of their
assessment and who were able to retrieve FGM/C cases
from records was 0.76% in contrast to 1.22% of practices
who were uncertain and were not able to retrieve the
numbers from medical records.
Indirect estimation
Results from indirect estimation of FGM/C show that in
2018, 168,525 women gave birth, of whom 3816 were
first-generation women whose country of origin is one
of the 29 countries where FGM/C is concentrated (see
Additional file 1). Of these women, about 2614 have
most probably undergone FGM/C. Also, about 40% of
these women are estimated to have been infibulated.
Based on these figures, the expected FGM/C prevalence
in women giving birth was thus estimated at 1.55%.
Discussion
In this nationwide survey of primary-care midwifery
practices on the prevalence of FGM/C, 336 of all eligible
503 practices participated, resulting in a 66.8% response,
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comprising 57.5% of all deliveries in 2018 in the
Netherlands. Midwives reported 523 cases of FGM/C,
constituting a prevalence of 0.54%. This indicates that 5
in 1000 women were reported as having undergone
some form of FGM/C. This estimate was influenced by
the extent to which midwives were certain about their
assessment and their ability to retrieve FGM/C cases
from medical records. The indirect estimation of FGM/
C in an extrapolation-model resulted in an estimated
prevalence of 1.55%.
Several reasons could explain the lower prevalence of
FGM/C in midwifery practices as compared to indirect
estimates of FGM/C. First, midwives reported on only
57.5% of the pregnant population in the Netherlands.
Nonresponding midwives were mainly practicing in the
larger urban areas (i.e., Amsterdam, Den Haag, Rotter-
dam). In the sensitivity analysis, we found no effect of
urbanisation on the prevalence of FGM/C. Hence, the
lower response in the larger cities in the Netherlands
will most likely not have influenced our estimate of
FGM/C prevalence. Given the lack of information re-
garding the countries of origin of women whose FGM/C
status was provided by the midwifery practices, it was
not possible to control for differences between the com-
positional differences between the population covered in
the direct estimation exercise and data provided by the
Statistics Netherlands. Second, recent studies show that
health care providers experience difficulties recognizing,
classifying and recording FGM/C due to, among others,
demanding work schedules and insufficient awareness of
FGM/C [19–21]. This corresponds to our findings of
midwives not being able to record or retrieve FGM/C
cases from medical records. Consequently, as we have
demonstrated, not being able to retrieve FGM/C cases
from records and uncertainty about FGM/C cases re-
ported is associated with overestimating FGM/C cases.
Therefore, in order to obtain accurate information about
the occurrence of FGM/C, data regarding FGM/C
should be systemically recorded in the national registra-
tion system. Finally, in the Netherlands, about 37.2% of
pregnant women are referred to obstetricians during
their pregnancy [18]. Hence, it is possible that FGM/C
status of these women was not assessed by the midwives,
who are the first point of contact in the Netherlands, be-
fore referral to an obstetrician, resulting in underreport-
ing of FGM/C cases; this could be the case especially for
cut women who may experience complications.
Using the extrapolation-model, it is also possible that
we have overestimated the (expected) prevalence of
FGM/C in women giving birth. Evidence shows that mi-
grants represent a selected sample of people compared
to stayers at the country of origin, that may originate
from upper and middle-class families supporting the dis-
continuation of the practice [25]. There is evidence indi-
cating that migration is a selective process [26]. Previous
studies have documented that migrants are usually
younger, wealthier and more educated than their coun-
terparts in the country of origin. In many countries
where FGM/C is practiced, lower age and higher levels
of wealth and education or urban residence are often as-
sociated with lower occurrence of FGM/C. As a conse-
quence, combining data on FGM/C prevalence in
country of origin with data on female migrants in coun-
try of destination is likely to overestimate most country
related indirect estimates of FGM/C prevalence. Al-
though we were able to adjust for variation in the FGM/
C prevalence among regions in countries of origin and
age, a future study would need to adjust FGM/C preva-
lence according to other components of the selection
hypothesis (i.e., educational level and wealth).
To our best knowledge, only the study by Korfker
et al. [26] is the closest to ours. In their study on the
prevalence of FGM/C among women delivering in the
Netherlands, they reported direct- and indirect estimates
of 0.32 and 0.7%, respectively. For indirect estimation of
FGM/C, the authors have combined the number of
women delivering from 15 countries where FGM/C is
practiced with the national prevalence of FGM/C in
their countries of origin. However, the authors were not
able to correct indirect estimation on the basis of
women’s birth places and ages upon arrival in the
Netherlands, which may have resulted in under- or
Table 1 Estimated FGM/C prevalence in midwifery practices, according to certainty of recognition and retrieval medical records
Number of midwifery
practices
Number of women
in care
Number of cut women
in care
Prevalence
(%)
95% Confidence
Interval
All midwifery practices 319 96,932 523 0.54 0.536–0.543
Midwifery practices with cut women
in care
167 60,651 522a 0.86 0.854–0.867
Certain. retrieved 25 26,040 198 0.76 0.751–0.770
Certain. unretrieved 74 6555 38 0.58 0.566–0.594
Uncertain. retrieved 21 9104 55 0.60 0.592–0.617
Uncertain. unretrieved 47 18,952 231 1.22 1.202–1.236
aData on ‘certainty’ and ‘retrieval from medical records’ were missing from one midwifery practice
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overestimation of FGM/C. In contrast, adjustments were
made in the current study to account for variation in
FGM/C prevalence among regions in the country of ori-
gin and age upon arrival in the Netherlands, possibly
providing a more accurate prevalence estimate. None-
theless, indirect estimation of FGM/C has methodo-
logical limitations, including possible inaccuracy of
estimation, for instance, related to the process of social,
geographical and selection of migrants [15]. Further-
more, in our survey about 32% of FGM/C cases were
classified as infibulation, while in the study by Korfker
et al. [26] slightly higher prevalence of infibulation was
found (40%). No other studies were found in the litera-
ture, it is therefore difficult to compare our findings with
studies in other settings or other population groups.
Direct estimation of FGM/C is regarded as the preferred
approach to estimate the prevalence of FGM/C in dias-
pora [15]. The current study has provided insight into dir-
ect estimation of FGM/C through a survey of midwifery
practices in the Netherlands. Evidence based on midwifery
practices data can be regarded as a minimum benchmark
for the actual prevalence among the subpopulation of
women who gave birth in a given year. The shortcomings
of our direct estimation are inherent to its retrospective
design, and the possible inaccuracies of FGM/C cases re-
ported due to recall error. Despite these limitations, the
present study still provides robust evidence of the pres-
ence of women with FGM/C in the Netherlands.
Conclusions
In the present study, we aimed to estimate the preva-
lence of FGM/C through a survey of midwifery practices
in the Netherlands. Midwives reported 523 cases of
FGM/C, constituting a prevalence of 0.54%. This sug-
gests that 5 in 1000 women were reported as having
undergone some form of FGM/C. Evidence based on
midwifery practices data can be regarded as a minimum
benchmark for actual prevalence among the subpopula-
tion of women who gave birth in a given year. Our find-
ings underline the importance of appropriate healthcare
for those who have undergone FGM/C. Therefore, cap-
acity building for healthcare professionals such as mid-
wives and the implementation of guidelines on the
management of FGM/C, which are currently being de-
veloped by the Dutch Society of Obstetrics and Gynae-
cology (NVOG), should be priorities in the Netherlands.
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